As always, we spotlight peer-reviewed research and public-health guidance from top journals and agencies. Many of these advances—especially vaccines, prevention, and diagnostics—are powered by sustained public funding (often including NIH grants). Translation to everyday care takes time; nothing here is medical advice. Talk to your clinician before changing meds, supplements, or treatment plans.
🔥 The hidden health toll of wildfires
What’s new: A research letter estimates hundreds of excess deaths tied to the January 2025 Los Angeles wildfires—far beyond the official death count—highlighting how smoke and disruption strain hearts and lungs.
Why it matters: It’s a reminder that wildfire risk isn’t just flames; smoke-driven heart/lung events and access-to-care issues add to the toll.
Journal/source: JAMA
💊 Big results for a weight-loss pill
What’s new: In a large trial, once-daily oral semaglutide 25 mg led to ~16–17% average weight loss vs ~3% with placebo over 68–72 weeks.
Why it matters: Injectable-level benefits—in a pill—could make evidence-based weight management easier to access.
Journal/source: NEJM (OASIS-4)
🧠 “Nerves feed tumors”: brain-style synapses drive lung cancer
What’s new: Scientists found functional synapses between neurons and small-cell lung cancer (SCLC) cells; blocking neuronal signaling (e.g., with levetiracetam) reduced tumor growth in models.
Why it matters: Reframes some cancers as neuro-dependent and points to repurposed neuro drugs as add-on therapies.
Journal/source: Nature
👶 One shot to protect babies from RSV
What’s new: In a phase 2b/3 trial of 3,600+ infants, clesrovimab—a long-acting antibody—reduced RSV illness and hospitalizations vs placebo.
Why it matters: A single shot before RSV season could keep more babies out of the hospital.
Journal/source: NEJM
🧠 “False Dementia”—is treatable
What’s new: A double-blind clinical trial showed shunt surgery improved gait/balance at 3 months in idiopathic normal-pressure hydrocephalus (iNPH); changes in cognition/bladder symptoms were less clear.
Why it matters: Some older adults labeled with “dementia” actually have fixable hydrocephalus—this helps guide decisions.
Journal/source: NEJM
🧪 An 11-minute self-test (+ blood test) to catch Alzheimer’s earlier
What’s new: A brief self-administered digital test (“BioCog”) outperformed standard clinic tests; combined with a blood biomarker, accuracy hit ~90% for detecting Alzheimer’s in primary care.
Why it matters: Faster, easier triage before expensive scans or specialist waits.
Journal/source: Nature Medicine
🧴 A cheap pill that helps prevent colon cancer coming back (for the right patients)
What’s new: In the ALASCCA phase 3 trial, daily low-dose aspirin halved 3-year recurrence after surgery in colorectal cancer patients with PI3K-pathway mutations (~37% of patients).
Why it matters: Genetics-guided use of a $0.05 pill—with bleeding risks considered—could meaningfully improve outcomes.
Journal/source: NEJM
🫀 Surgery vs. GLP-1s: long-term outcomes
What’s new: Over ~10 years, metabolic surgery was linked to lower risks of death, major heart events, kidney disease, and retinopathy compared with GLP-1 medicines in people with type 2 diabetes and obesity.
Why it matters: GLP-1s are powerful, but surgery may deliver deeper, longer-term protection for some.
Journal/source: Nature Medicine
🌿 Cannabis & fertility: early human evidence of risk
What’s new: A Nature Communications study found THC in follicular fluid and linked cannabis exposure to lower rates of chromosomally normal embryos in IVF patients; lab work suggested mechanisms.
Why it matters: Practical counseling data for people trying to conceive or undergoing IVF.
Journal/source: Nature Communications
🦠 Last flu season was rough—plan ahead
What’s new: CDC reports 2024–25 flu hospitalizations were the highest since 2010–11; only about one-third of hospitalized patients were vaccinated.
Why it matters: Get your flu shot and seek prompt antivirals if you’re very sick or high-risk.
Journal/source: CDC MMWR
Stay Curious,
Science Rabbit Team
Leave a Reply